- CSR Summary Not Available
- NCT00236665
- Primary Citation
- Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNutritional and Metabolic DiseasesEnrollment531% Female72%% White100%
Product ClassAnticonvulsantsSponsor Protocol NumberTOPMAT-OBHT-001Data PartnerJohnson & JohnsonCondition StudiedHypertension, ObesityMean/Median Age (Years)50
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available